← Leaderboards
Glenn Yiu
University Of California At Davis
$5,304,340
Attributed
$5,304,340
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2016–25$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,304,340 · 4
By mechanism
R01$3,960,049 · 2
K08$1,032,765 · 1
R21$311,526 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California At Davis
Same institution · by research overlap
- Kit S Lam$32,497,491
Others in their field
Top investigators on “Animals”
- David Heimbrook · Leidos Biomedical Research, Inc.$534,904,829
- Richard Webby · St. Jude Children'S Research Hospital$259,408,394
- Eric S Lander · Whitehead Institute For Biomedical Res$209,574,154
- Dennis R. Burton · Scripps Research Institute$204,129,233
- Richard K. Wilson · Washington University$130,501,539
- Mark S Klempner · Tufts Medical Center$129,182,794
Research focus
AnimalsStructure Of Retinal Pigment EpitheliumIn VivoCellsOptical Coherence TomographyBlindnessImageElderlyAge Related Macular DegenerationPathogenesisTissuesBindingMetabolicImaging TechnologyCostInsightImmunohistochemistryBaseNonhuman PrimateRetinaMaculaAnimal ModelImmuneIn Vivo Imaging
Grant awards (12)
Optimizing suprachoroidal AAV delivery in nonhuman primates for retinal gene therapies$719,012
R01 · FY2025 · EY · contact PI
Soft drusen in rhesus macaques as a nonhuman primate model of early age-related macular degeneration$672,319
R01 · FY2025 · EY · contact PI
Soft drusen in rhesus macaques as a nonhuman primate model of early age-related macular degeneration$659,117
R01 · FY2024 · EY · contact PI
Soft drusen in rhesus macaques as a nonhuman primate model of early age-related macular degeneration$684,798
R01 · FY2023 · EY · contact PI
Soft drusen in rhesus macaques as a nonhuman primate model of early age-related macular degeneration$633,815
R01 · FY2022 · EY · contact PI
Soft drusen in rhesus macaques as a nonhuman primate model of early age-related macular degeneration$590,988
R01 · FY2021 · EY · contact PI
A nanoparticle platform for targeted delivery of therapeutic agents to retinal pigment epithelial or choroidal endothelial cells$206,553
K08 · FY2020 · EY · contact PI
Optogenetic Control of Oxidative Stress as a Model of Geographic Atrophy$311,526
R21 · FY2019 · EY · contact PI
A nanoparticle platform for targeted delivery of therapeutic agents to retinal pigment epithelial or choroidal endothelial cells$206,553
K08 · FY2019 · EY · contact PI
A nanoparticle platform for targeted delivery of therapeutic agents to retinal pigment epithelial or choroidal endothelial cells$206,553
K08 · FY2018 · EY · contact PI
A nanoparticle platform for targeted delivery of therapeutic agents to retinal pigment epithelial or choroidal endothelial cells$206,553
K08 · FY2017 · EY · contact PI
A nanoparticle platform for targeted delivery of therapeutic agents to retinal pigment epithelial or choroidal endothelial cells$206,553
K08 · FY2016 · EY · contact PI